YY1 transcription factor induces proliferation and aerobic glycolysis of neuroblastoma cells via LDHA regulation

Wang,Qiang; Fan,Wei; Liang,Bingxue; Hou,Bowen; Jiang,Zaiqun; Li,Chao

doi:10.3892/etm.2022.11736

YY1 transcription factor induces proliferation and aerobic glycolysis of neuroblastoma cells via LDHA regulation

Authors:
- Qiang Wang
- Wei Fan
- Bingxue Liang
- Bowen Hou
- Zaiqun Jiang
- Chao Li
View Affiliations

Affiliations: Department of Pediatric Surgery, The First Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang 150001, P.R. China
Published online on: November 29, 2022 https://doi.org/10.3892/etm.2022.11736
Article Number: 37

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

The present study investigated the effect of transcription factor yin yang 1 (YY1) on aerobic glycolysis and cell proliferation in neuroblastoma and its mechanism. Neuroblastoma cell lines were used to investigate the association between YY1 and lactate dehydrogenase A (LDHA) expression. Cell Counting Kit (CCK)‑8 and clone formation experiments were used to detect the cell viability. The interaction of YY1 and LDHA was detected using chromatin immunoprecipitation assay. Glucose uptake, intra/extracellular lactate and pyruvate and LDHA expression were evaluated using standard methods. Reverse transcription quantitative PCR, western blotting and gene overexpression or silencing were undertaken to explore the biological effects and underlying mechanisms of transcriptional regulators in NB cells. The results demonstrated that YY1 was significantly upregulated in neuroblastoma cell lines. The results of aerobic glycolysis and CCK‑8 indicated that YY1 significantly promoted the proliferation and aerobic glycolysis of neuroblastoma cells. In addition, chromatin immunoprecipitation‑PCR results demonstrated that YY1 was directly bound to the promoter LDHA. Overexpression of LDHA could reverse the inhibitory effect of sh‑YY1 on aerobic glycolysis and proliferation of neuroblastoma cells. In conclusion, YY1 could induce aerobic glycolysis and proliferation of neuroblastoma cell lines, and may directly mediate the regulation of LDHA. These findings may provide novel insight for the treatment of neuroblastoma.

View Figures

View References

1	Westerveld ASR, van Dalen EC, Asogwa OA, Koopman MMW, Papadakis V, Laureys G, van der Pal HJH, Kremer LCM, Tytgat GAM and Teepen JC: Neuroblastoma survivors at risk for developing subsequent neoplasms: A systematic review. Cancer Treat Rev. 104(102355)2022.PubMed/NCBI View Article : Google Scholar
2	Mlakar V, Morel E, Mlakar SJ, Ansari M and Gumy-Pause F: A review of the biological and clinical implications of RAS-MAPK pathway alterations in neuroblastoma. J Exp Clin Cancer Res. 40(189)2021.PubMed/NCBI View Article : Google Scholar
3	Li Y, Lu T, Wang J, Zhuo Z, Miao L, Yang Z, Zhang J, Cheng J, Zhou H, Li S, et al: YTHDC1 gene polymorphisms and neuroblastoma susceptibility in Chinese children. Aging (Albany NY). 13:25426–25439. 2021.PubMed/NCBI View Article : Google Scholar
4	Bona K, Li Y, Winestone LE, Getz KD, Huang YS, Fisher BT, Desai AV, Richardson T, Hall M, Naranjo A, et al: Poverty and targeted immunotherapy: Survival in Children's oncology group clinical trials for high-risk neuroblastoma. J Natl Cancer Inst. 113:282–291. 2021.PubMed/NCBI View Article : Google Scholar
5	Voeller J, Erbe AK, Slowinski J, Rasmussen K, Carlson PM, Hoefges A, VandenHeuvel S, Stuckwisch A, Wang X, Gillies SD, et al: Combined innate and adaptive immunotherapy overcomes resistance of immunologically cold syngeneic murine neuroblastoma to checkpoint inhibition. J Immunother Cancer. 7(344)2019.PubMed/NCBI View Article : Google Scholar
6	Ganapathy-Kanniappan S: Molecular intricacies of aerobic glycolysis in cancer: Current insights into the classic metabolic phenotype. Crit Rev Biochem Mol Biol. 53:667–682. 2018.PubMed/NCBI View Article : Google Scholar
7	Lei S, Yang J, Chen C, Sun J, Yang L, Tang H, Yang T, Chen A, Zhao H, Li Y and Du X: FLIP(L) is critical for aerobic glycolysis in hepatocellular carcinoma. J Exp Clin Cancer Res. 35(79)2016.PubMed/NCBI View Article : Google Scholar
8	Qu H, Qi D, Wang X, Dong Y, Jin Q, Wei J and Quan C: CLDN6 Suppresses c-MYC-Mediated aerobic glycolysis to inhibit proliferation by TAZ in breast cancer. Int J Mol Sci. 23(129)2021.PubMed/NCBI View Article : Google Scholar
9	Xie Y, Wang M, Xia M, Guo Y, Zu X and Zhong J: Ubiquitination regulation of aerobic glycolysis in cancer. Life Sci. 292(120322)2022.PubMed/NCBI View Article : Google Scholar
10	Ponnusamy L, Natarajan SR and Manoharan R: MARK2 potentiate aerobic glycolysis-mediated cell growth in breast cancer through regulating mTOR/HIF-1α and p53 pathways. J Cell Biochem. 123:759–771. 2022.PubMed/NCBI View Article : Google Scholar
11	Wu H, Wang X, Wu T and Yang S: miR-489 suppresses multiple myeloma cells growth through inhibition of LDHA-mediated aerobic glycolysis. Genes Genomics. 42:291–297. 2020.PubMed/NCBI View Article : Google Scholar
12	Panneerpandian P, Devanandan HJ, Marimuthu A, Karthikeyan C and Ganesan K: Abacavir induces the transcriptional activity of YY1 and other oncogenic transcription factors in gastric cancer cells. Antiviral Res. 174(104695)2020.PubMed/NCBI View Article : Google Scholar
13	Warowicka A, Broniarczyk J, Węglewska M, Kwaśniewski W and Goździcka-Józefiak A: Dual Role of YY1 in HPV life cycle and cervical cancer development. Int J Mol Sci. 23(3453)2022.PubMed/NCBI View Article : Google Scholar
14	Xu C, Tsai YH, Galbo PM, Gong W, Storey AJ, Xu Y, Byrum SD, Xu L, Whang YE, Parker JS, et al: Cistrome analysis of YY1 uncovers a regulatory axis of YY1:BRD2/4-PFKP during tumorigenesis of advanced prostate cancer. Nucleic Acids Res. 49:4971–4988. 2021.PubMed/NCBI View Article : Google Scholar
15	Li W, Hu S, Han Z and Jiang X: YY1-Induced transcriptional activation of FAM111B contributes to the malignancy of breast cancer. Clin Breast Cancer. 22:e417–e425. 2022.PubMed/NCBI View Article : Google Scholar
16	Liu SS, Li Y, Zhang H, Zhang D, Zhang XB, Wang X and Yu Y: The ERα-miR-575-p27 feedback loop regulates tamoxifen sensitivity in ER-positive breast cancer. Theranostics. 10:10729–10742. 2020.PubMed/NCBI View Article : Google Scholar
17	Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods. 25:402–408. 2001.PubMed/NCBI View Article : Google Scholar
18	Ma X, Li C, Sun L, Huang D, Li T, He X, Wu G, Yang Z, Zhong X, Song L, et al: Lin28/let-7 axis regulates aerobic glycolysis and cancer progression via PDK1. Nat Commun. 5(5212)2014.PubMed/NCBI View Article : Google Scholar
19	Jiménez C, Antonelli R, Nadal-Ribelles M, Devis-Jauregui L, Latorre P, Solé C, Masanas M, Molero-Valenzuela A, Soriano A, Sánchez de Toledo J, et al: Structural disruption of BAF chromatin remodeller impairs neuroblastoma metastasis by reverting an invasiveness epigenomic program. Mol Cancer. 21(175)2022.PubMed/NCBI View Article : Google Scholar
20	Xie M, Fu XG and Jiang K: Notch1/TAZ axis promotes aerobic glycolysis and immune escape in lung cancer. Cell Death Dis. 12(832)2021.PubMed/NCBI View Article : Google Scholar
21	Fang E, Wang X, Wang J, Hu A, Song H, Yang F, Li D, Xiao W, Chen Y, Guo Y, et al: Therapeutic targeting of YY1/MZF1 axis by MZF1-uPEP inhibits aerobic glycolysis and neuroblastoma progression. Theranostics. 10:1555–1571. 2020.PubMed/NCBI View Article : Google Scholar
22	Li B, Wang J, Liao J, Wu M, Yuan X, Fang H, Shen L and Jiang M: YY1 promotes pancreatic cancer cell proliferation by enhancing mitochondrial respiration. Cancer Cell Int. 22(287)2022.PubMed/NCBI View Article : Google Scholar
23	Gao G, Li X, Zhang J and Yu H: YY1 as a promoter regulating the circ_0001946/miR-671-5p/EGFR axis to promote chemotherapy resistance in breast cancer cells. Am J Transl Res. 14:2550–2566. 2022.PubMed/NCBI
24	Xu P, Xiao H, Yang Q, Hu R, Jiang L, Bi R, Jiang X, Wang L, Mei J, Ding F and Huang J: The USP21/YY1/SNHG16 axis contributes to tumor proliferation, migration, and invasion of non-small-cell lung cancer. Exp Mol Med. 52:41–55. 2020.PubMed/NCBI View Article : Google Scholar
25	Wang Y, Wu S, Huang C, Li Y, Zhao H and Kasim V: Yin Yang 1 promotes the Warburg effect and tumorigenesis via glucose transporter GLUT3. Cancer Sci. 109:2423–2434. 2018.PubMed/NCBI View Article : Google Scholar
26	Zhou S, Li P, Qin L, Huang S and Dang N: Transcription factor YY1 contributes to human melanoma cell growth through modulating the p53 signalling pathway. Exp Dermatol. 31:1563–1578. 2022.PubMed/NCBI View Article : Google Scholar
27	Koukourakis MI, Giatromanolaki A, Bougioukas G and Sivridis E: Lung cancer: A comparative study of metabolism related protein expression in cancer cells and tumor associated stroma. Cancer Biol Ther. 6:1476–1479. 2007.PubMed/NCBI View Article : Google Scholar
28	Zhou Y, Guo Y and Tam KY: Targeting glucose metabolism to develop anticancer treatments and therapeutic patents. Expert Opin Ther Pat. 32:441–453. 2022.PubMed/NCBI View Article : Google Scholar
29	Roy S, Leidal AM, Ye J, Ronen SM and Debnath J: Autophagy-Dependent Shuttling of TBC1D5 controls plasma membrane translocation of GLUT1 and glucose uptake. Mol Cell. 67:84–95.e5. 2017.PubMed/NCBI View Article : Google Scholar
30	Li Y, He L, Wang Y, Tan Y and Zhang F: N⁶-methyladenosine methyltransferase KIAA1429 elevates colorectal cancer aerobic glycolysis via HK2-dependent manner. Bioengineered. 13:11923–11932. 2022.PubMed/NCBI View Article : Google Scholar
31	Chatterjee N, Pazarentzos E, Mayekar MK, Gui P, Allegakoen DV, Hrustanovic G, Olivas V, Lin L, Verschueren E, Johnson JR, et al: Synthetic essentiality of metabolic regulator PDHK1 in PTEN-Deficient cells and cancers. Cell Rep. 28:2317–2330.e8. 2019.PubMed/NCBI View Article : Google Scholar
32	Sheppard S, Santosa EK, Lau CM, Violante S, Giovanelli P, Kim H, Cross JR, Li MO and Sun JC: Lactate dehydrogenase A-dependent aerobic glycolysis promotes natural killer cell anti-viral and anti-tumor function. Cell Rep. 35(109210)2021.PubMed/NCBI View Article : Google Scholar
33	Hua S, Liu C, Liu L and Wu D: miR-142-3p inhibits aerobic glycolysis and cell proliferation in hepatocellular carcinoma via targeting LDHA. Biochem Biophys Res Commun. 496:947–954. 2018.PubMed/NCBI View Article : Google Scholar
34	Han RL, Wang FP, Zhang PA, Zhou XY and Li Y: miR-383 inhibits ovarian cancer cell proliferation, invasion and aerobic glycolysis by targeting LDHA. Neoplasma. 64:244–252. 2017.PubMed/NCBI View Article : Google Scholar